Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Lipoprotein lipase expression in unmutated CLL patients is the consequence of a demethylation process induced by the microenvironment

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Dighiero G, Hamblin TJ . Chronic lymphocytic leukaemia. Lancet 2008; 371: 1017–1029.

    Article  CAS  Google Scholar 

  2. Caligaris-Cappio F . Role of the microenvironment in chronic lymphocytic leukaemia. Br J Haematol 2003; 123: 380–388.

    Article  Google Scholar 

  3. Zenz T, Fulda S, Stilgenbauer S . More (on) prognostic factors in chronic lymphocytic leukemia. Leuk Lymphoma 2010; 51: 5–6.

    Article  Google Scholar 

  4. Oppezzo P, Vasconcelos Y, Settegrana C, Jeannel D, Vuillier F, Legarff-Tavernier M et al. The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia. Blood 2005; 106: 650–657.

    Article  CAS  Google Scholar 

  5. Heintel D, Kienle D, Shehata M, Krober A, Kroemer E, Schwarzinger I et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia 2005; 19: 1216–1223.

    Article  CAS  Google Scholar 

  6. Sevov M, Kaderi M, Kanduri M, Mansouri, Buhl A, Cahill N et al. A comparative study of RNA-based markers in chronic lymphocytic leukemia reveals LPL as a powerful predictor of clinical outcome. Haematologica 2009; 94 (Suppl 3): 1–95.

    Google Scholar 

  7. Van Bockstaele F, Pede V, Janssens A, Callewaert F, Offner F, Verhasselt B et al. Lipoprotein lipase mRNA expression in whole blood is a prognostic marker in B cell chronic lymphocytic leukemia. Clin Chem 2007; 53: 204–212.

    Article  CAS  Google Scholar 

  8. Kaderi MA, Kanduri M, Buhl AM, Sevov M, Cahill N, Gunnarsson R et al. LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia. Haematologica 2011; 96: 1153–1160.

    Article  Google Scholar 

  9. Kolset SO, Salmivirta M . Cell surface heparan sulfate proteoglycans and lipoprotein metabolism. Cell Mol Life Sci 1999; 56: 857–870.

    Article  CAS  Google Scholar 

  10. Pallasch CP, Schwamb J, Konigs S, Schulz A, Debey S, Kofler D et al. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia 2008; 22: 585–592.

    Article  CAS  Google Scholar 

  11. Brenet F, Moh M, Funk P, Feierstein E, Viale AJ, Socci ND et al. DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One 2011; 6: e14524.

    Article  CAS  Google Scholar 

  12. Watanabe M, Ogawa Y, Itoh K, Koiwa T, Kadin ME, Watanabe T et al. Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma. Lab Invest 2008; 88: 48–57.

    Article  CAS  Google Scholar 

  13. Bilban M, Heintel D, Scharl T, Woelfel T, Auer MM, Porpaczy E et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia 2006; 20: 1080–1088.

    Article  CAS  Google Scholar 

  14. Burger JA . Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting. Semin Cancer Biol 2010; 20: 424–430.

    Article  CAS  Google Scholar 

  15. Palacios F, Moreno P, Morande P, Abreu C, Correa A, Porro V et al. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease. Blood 2010; 115: 4488–4496.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from CHLCC (Comisión Honoraria de Lucha contra el Cáncer) and ANII (Agencia Nacional de Investigación e Innovación), Montevideo, Uruguay. We wish to thank Gonzalo Obal, Gonzalo Moratorio and Cecilia Portela for technical assistance, Dr Otto Pritsch and Dr Miquel Llobera for critical comments, Dr J Brunzell for anti-LPL antibody and Mrs Ivana Faccini for helpful secretarial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Oppezzo.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreno, P., Abreu, C., Borge, M. et al. Lipoprotein lipase expression in unmutated CLL patients is the consequence of a demethylation process induced by the microenvironment. Leukemia 27, 721–725 (2013). https://doi.org/10.1038/leu.2012.212

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2012.212

This article is cited by

Search

Quick links